Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $1.373B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $245M | 17.9% | $9.81 | +1385.0% | COM | 632307104 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $118M | 8.6% | $15.35 | +188.4% | CL A | 92337R101 |
| GILD | Gilead Sciences Inc | 774,227 | $71.52M | 5.2% | $87.00 | 0.0% | COM | 375558103 |
| ABBV | AbbVie Inc | 359,393 | $63.86M | 4.7% | $177.41 | 0.0% | COM | 00287Y109 |
| JAZZ | Jazz Pharmaceuticals PLC | 504,193 | $62.09M | 4.5% | $114.77 | +2.7% | SHS USD | G50871105 |
| SRPT | Sarepta Therapeutics Inc | 428,771 | $52.13M | 3.8% | $122.55 | 0.0% | COM | 803607100 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $45.2M | 3.3% | $20.17 | +42.3% | COM | 04272N102 |
| AZN | AstraZeneca PLC | 651,344 | $42.68M | 3.1% | $73.21 | — | SPONSORED ADR | 046353108 |
| SYK | Stryker Corporation | 116,005 | $41.77M | 3.0% | $366.32 | 0.0% | COM | 863667101 |
| AXSM | Axsome Therapeutics Inc | 491,726 | $41.6M | 3.0% | $80.00 | +15.0% | COM | 05464T104 |
| REPL | Replimune Group Inc | 3,149,522 | $38.14M | 2.8% | $12.12 | +0.3% | COM | 76029N106 |
| INCY | Incyte Corp | 524,267 | $36.21M | 2.6% | $63.77 | +11.7% | COM | 45337C102 |
| RAPP | Rapport Therapeutics Inc | 1,995,594 | $35.4M | 2.6% | $23.12 | -4.1% | COM | 75383L102 |
| SLNO | Soleno Therapeutics Inc | 757,248 | $34.04M | 2.5% | $45.28 | +14.4% | COM | 834203309 |
| BSX | Boston Scientific Corp | 346,571 | $30.96M | 2.3% | $77.15 | +14.1% | COM | 101137107 |
| IDYA | IDEAYA Biosciences Inc | 1,069,090 | $27.48M | 2.0% | $31.22 | -9.3% | COM | 45166A102 |
| ALNY | Alnylam Pharmaceuticals Inc | 110,157 | $25.92M | 1.9% | $262.99 | 0.0% | COM | 02043Q107 |
| ALKS | Alkermes Plc | 894,266 | $25.72M | 1.9% | $28.75 | 0.0% | SHS | G01767105 |
| DYN | Dyne Therapeutics Inc | 1,071,498 | $25.24M | 1.8% | $20.14 | +46.9% | COM | 26818M108 |
| DXCM | Dexcom Inc | 290,210 | $22.57M | 1.6% | $74.04 | 0.0% | COM | 252131107 |
| RYTM | Rhythm Pharmaceuticals Inc | 397,428 | $22.25M | 1.6% | $50.14 | +10.2% | COM | 76243J105 |
| GMED | Globus Med Inc | 244,700 | $20.24M | 1.5% | $78.87 | 0.0% | CL A | 379577208 |
| ISRG | Intuitive Surgical Inc | 37,896 | $19.78M | 1.4% | $520.85 | 0.0% | COM | 46120E602 |
| INSM | Insmed Inc | 256,281 | $17.69M | 1.3% | $45.95 | +56.7% | COM PAR $.01 | 457669307 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $17.18M | 1.3% | $26.75 | — | COM | 984241109 |
| SVRA | Savara Inc | 5,471,299 | $16.8M | 1.2% | $4.16 | -16.3% | COM | 805111101 |
| JANX | Janux Therapeutics Inc | 253,262 | $13.56M | 1.0% | $46.79 | +13.1% | COM | 47103J105 |
| BIOA | BioAge Labs Inc | 2,304,901 | $13.35M | 1.0% | $20.04 | -13.9% | COM | 09077V100 |
| — | Inozyme Pharma Inc | 4,280,308 | $11.86M | 0.9% | $14.88 | — | COM | 45790W108 |
| LLY | Eli Lilly & Co | 14,364 | $11.09M | 0.8% | $821.14 | 0.0% | COM | 532457108 |
| EWTX | Edgewise Therapeutics Inc | 402,773 | $10.75M | 0.8% | $18.09 | +76.1% | COM | 28036F105 |
| PHVS | Pharvaris N V | 560,723 | $10.75M | 0.8% | $21.02 | -2.1% | COM | N69605108 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $9.961M | 0.7% | $22.83 | — | COM | 008064107 |
| — | Inari Med Inc | 180,456 | $9.212M | 0.7% | $49.59 | — | COM | 45332Y109 |
| SNDX | Syndax Pharmaceuticals Inc | 658,627 | $8.707M | 0.6% | $21.11 | -18.9% | COM | 87164F105 |
| AXSM | Axsome Therapeutics Inc | 100,000 | $8.461M | 0.6% | $80.00 | +15.0% | Call | 05464T104 |
| INBX | Inhibrx Biosciences Inc | 527,190 | $8.119M | 0.6% | $15.41 | -1.1% | COM | 45720N103 |
| IMNM | Immunome Inc | 746,824 | $7.931M | 0.6% | $18.97 | -36.3% | COM | 45257U108 |
| COGT | Cogent Biosciences Inc | 823,160 | $6.421M | 0.5% | $6.37 | +56.5% | COM | 19240Q201 |
| ACHV | Achieve Life Sciences Inc | 1,306,482 | $4.599M | 0.3% | $4.45 | +1.8% | COM | 004468500 |
| ERAS | Erasca Inc | 1,795,880 | $4.508M | 0.3% | $2.21 | +24.1% | COM | 29479A108 |
| ESTA | Establishment Labs Hldgs Inc | 95,305 | $4.391M | 0.3% | $47.17 | -7.6% | COM | G31249108 |
| AVTR | Avantor Inc | 200,000 | $4.214M | 0.3% | $22.49 | 0.0% | COM | 05352A100 |
| EW | Edwards Lifesciences Corp | 40,000 | $2.961M | 0.2% | $88.55 | -21.0% | COM | 28176E108 |
| EXAS | Exact Sciences Corp | 52,042 | $2.924M | 0.2% | $62.97 | -1.2% | COM | 30063P105 |
| IMTX | Immatics N.V | 343,206 | $2.44M | 0.2% | $9.86 | -12.8% | SHS | N44445109 |
| DHR | Danaher Corporation | 10,000 | $2.296M | 0.2% | $243.95 | 0.0% | COM | 235851102 |
| — | Nextcure Inc | 2,671,856 | $2.06M | 0.2% | $10.01 | — | COM | 65343E108 |
| ANAB | AnaptysBio Inc | 132,927 | $1.76M | 0.1% | $24.22 | 0.0% | COM | 032724106 |
| KROS | Keros Therapeutics Inc | 95,375 | $1.51M | 0.1% | $51.97 | 0.0% | COM | 492327101 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $1.474M | 0.1% | $32.91 | — | COM | 097702104 |
| IRON | Disc Medicine Inc | 22,752 | $1.442M | 0.1% | $42.38 | +36.5% | COM | 254604101 |
| BDX | Becton Dickinson & Co | 4,951 | $1.123M | 0.1% | $227.63 | -1.1% | COM | 075887109 |
| VIR | Vir Biotechnology Inc | 114,131 | $838K | 0.1% | $8.69 | -9.2% | COM | 92764N102 |
| ICUI | ICU Med Inc | 5,000 | $776K | 0.1% | $169.13 | 0.0% | COM | 44930G107 |
| ELVN | Enliven Therapeutics Inc | 34,025 | $766K | 0.1% | $25.92 | 0.0% | COM | 29337E102 |
| — | Ikena Oncology Inc | 382,616 | $627K | 0.0% | $2.66 | — | COM | 45175G108 |
| TVTX | Travere Therapeutics Inc | 32,616 | $568K | 0.0% | $17.69 | 0.0% | COM | 89422G107 |
| GPCR | Structure Therapeutics Inc | 20,892 | $567K | 0.0% | $45.34 | — | SPONSORED ADS | 86366E106 |
| LUNG | Pulmonx Corp | 61,326 | $416K | 0.0% | $7.67 | -14.2% | COM | 745848101 |
| RNAM | Avidity Biosciences Inc | 13,789 | $401K | 0.0% | $33.06 | +26.4% | COM | 05370A108 |